A clinical trial has backed the safety and efficacy of one of Novo Nordisk's weight-loss medicines in children as young as six, showing a significant drop in body mass index (BMI). The study used the ...
Novo Nordisk has won a Committee for Medicinal Products for Human Use (CHMP) endorsement for a higher-dose version of its diabetes drug liraglutide that can be used to treat obesity. The Danish ...
Both Victoza and Ozempic can help reduce the risk of heart attack and stroke in people with type 2 diabetes. Victoza is injected once daily, while Ozempic is injected once weekly. Victoza has more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback